Markets & Regulations

(Vacclav/iStock via Getty Images Plus)

Trump and COVID-19: treatments to date

By Jenni Spinner

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

(Nadzeya_Dzivakova/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Index survey reveals minds of CEOs

By Jenni Spinner

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.

(Anastasia Usenko/iStock via Getty Images Plus)

Deloitte survey reveals pharma CEO thoughts

By Jenni Spinner

The latest iteration of the company’s Pharma CEO Survey offers information and insight as to how key industry figures are planning for the future.

(ChakisAtelier/iStock via Getty Images Plus)

Latest COVID-19 news from the FDA

By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

(ClaudioVentrella/iStock via Getty Images Plus)

Breaking FDA COVID-19 news

By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

Current FDA COVID-19 news

Current FDA COVID-19 news

By Jenni Spinner

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

(Isabela Maia Studio/iStock via Getty Images Plus)

This week's FDA COVID-19 news

By Jenni Spinner

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments

Follow us

Products

View more

Webinars